Creative Planning’s Traws Pharma TRAW Stock Holding History

Creative Planning’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-116	Closed	-$17K	–	2115
2019 Q4	$17K	Buy	+116	New	+$21.7K	﹤0.01%	1888
2018 Q3	–	Sell	-10	Closed	-$22K	–	2185
2018 Q2	$22K	Buy	+10	New	+$29K	﹤0.01%	1907
2017 Q3	–	Hold	0	–	-$1K	–	3780
2017 Q2	–	Hold	0	–	–	–	4521
2017 Q1	–	Hold	0	–	–	–	4330
2016 Q4	–	Hold	0	–	–	–	4510
2016 Q3	–	Hold	0	–	–	–	4458
2016 Q2	–	Hold	0	–	–	–	3409
2016 Q1	–	Hold	0	–	–	–	3354
2015 Q4	–	Hold	0	–	–	–	2783

Other funds holding TRAW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HWA

Hillcrest Wealth Advisors Hazlet, New Jersey $279M AUM 21.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Quilter Plc London, United Kingdom $5.7B AUM 21.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Creative Planning's TRAW Position: Q1 2020 in Review

Creative Planning sold out of Traws Pharma (TRAW) in Q1 2020, closing a stake of 116 shares — an estimated $17K sold.

Creative Planning first reported a position in TRAW in Q2 2018 and held it in 2 quarters. The position peaked at $22K in Q2 2018. 21 funds tracked by Wall St. Rank hold TRAW as of Q1 2020.

Creative Planning reported no remaining Traws Pharma position as of Q1 2020 after selling out during the quarter.
Creative Planning sold 116 Traws Pharma shares in Q1 2020, an estimated $17K.
Creative Planning first reported a position in Traws Pharma in Q2 2018 and held it in 2 quarters.
Creative Planning's Traws Pharma position peaked at $22K in Q2 2018.
21 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2020.

Based on Creative Planning's 13F filing for Q1 2020, filed 5 May 2020.